The global renal biomarker market was estimated at USD 999 million in 2021 and is expected to hit USD 1,692 million by 2028, registering a CAGR of 7.5% from 2022 to 2028 as per the latest report by Gen Consulting Company.

The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global renal biomarker market. It traces the market’s historic and forecast market growth. The report identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches. This study also provides an analysis of the impact of the COVID-19 crisis on the renal biomarker industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the type, diagnostic technique, end user, and region. The global market for renal biomarker can be segmented by type: functional biomarker, up-regulated protein, others. Among these, the functional biomarker segment was accounted for the highest revenue generator in 2021. Renal biomarker market is further segmented by diagnostic technique: enzyme-linked immunosorbent assay, particle-enhanced turbidimetric immunoassay (PETIA), colorimetric assay, chemiluminescent enzyme immunoassay (CLIA), liquid chromatography mass spectrometry (LS-MS). The enzyme-linked immunosorbent assay segment is estimated to account for the largest share of the global renal biomarker market. Based on end user, the renal biomarker market is segmented into: hospital, diagnostic lab, others. The diagnostic lab segment held the largest share of the global renal biomarker market in 2021 and is anticipated to hold its share during the forecast period. On the basis of region, the renal biomarker market also can be divided into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. In 2021, North America made up the largest share of revenue generated by the renal biomarker market.

Market Segmentation
By type: functional biomarker, up-regulated protein, others
By diagnostic technique: enzyme-linked immunosorbent assay, particle-enhanced turbidimetric immunoassay (PETIA), colorimetric assay, chemiluminescent enzyme immunoassay (CLIA), liquid chromatography mass spectrometry (LS-MS)
By end user: hospital, diagnostic lab, others
By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America

The market research report covers the analysis of key stake holders of the global renal biomarker market. Some of the leading players profiled in the report include Abbott Laboratories, BioMerieux SA, Randox Laboratories Ltd., Roche Holding AG, Siemens Healthineers AG, Thermo Fisher Scientific Inc., among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report
– To analyze and forecast the market size of the global renal biomarker market.
– To classify and forecast the global renal biomarker market based on type, diagnostic technique, end user, region.
– To identify drivers and challenges for the global renal biomarker market.
– To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global renal biomarker market.
– To identify and analyze the profile of leading players operating in the global renal biomarker market.

Why Choose This Report
– Gain a reliable outlook of the global renal biomarker market forecasts from 2022 to 2028 across scenarios.
– Identify growth segments for investment.
– Stay ahead of competitors through company profiles and market data.
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.